结合
化学
三阴性乳腺癌
适体
乳腺癌
药品
抗体-药物偶联物
癌症
药理学
组合化学
癌症研究
内科学
免疫学
抗体
分子生物学
医学
单克隆抗体
数学分析
生物
数学
作者
Feng Xu,Jingtong Xu,Feng Han,Ke Wang,Fulong Wang,Hanyang Yu,Xiaoxiang Guan
标识
DOI:10.1021/acs.jmedchem.5c00492
摘要
Abstract Triple-negative breast cancer (TNBC) is a highly aggressive malignancy lacking targeted therapeutic modalities. Aptamers are promising targeting agents with high specificity and affinity. In this study, we identified a chemically modified nucleic acid aptamer (AptT1) that specifically recognized and internalized into TNBC cells. Mechanistic studies revealed that ANXA2 was an essential protein in facilitating AptT1 internalization via clathrin-mediated endocytosis. Furthermore, we constructed an aptamer-drug conjugate (ApDC) to selectively deliver a cytotoxic agent (SN38) to TNBC cells and demonstrated significant efficacy and safety in a TNBC xenograft model. These findings suggest that AptT1-based ApDC holds great potential as an innovative targeted strategy for TNBC.
科研通智能强力驱动
Strongly Powered by AbleSci AI